AU3567299A - Phytosterol formulations to lower cholesterol absorption - Google Patents

Phytosterol formulations to lower cholesterol absorption

Info

Publication number
AU3567299A
AU3567299A AU35672/99A AU3567299A AU3567299A AU 3567299 A AU3567299 A AU 3567299A AU 35672/99 A AU35672/99 A AU 35672/99A AU 3567299 A AU3567299 A AU 3567299A AU 3567299 A AU3567299 A AU 3567299A
Authority
AU
Australia
Prior art keywords
cholesterol absorption
lower cholesterol
phytosterol formulations
phytosterol
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35672/99A
Inventor
Eric Stohler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDICAL ISOTOPES Inc
Original Assignee
MEDICAL ISOTOPES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDICAL ISOTOPES Inc filed Critical MEDICAL ISOTOPES Inc
Publication of AU3567299A publication Critical patent/AU3567299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU35672/99A 1998-04-17 1999-04-16 Phytosterol formulations to lower cholesterol absorption Abandoned AU3567299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8211498P 1998-04-17 1998-04-17
US60082114 1998-04-17
PCT/US1999/008413 WO1999053925A1 (en) 1998-04-17 1999-04-16 Phytosterol formulations to lower cholesterol absorption

Publications (1)

Publication Number Publication Date
AU3567299A true AU3567299A (en) 1999-11-08

Family

ID=22169155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35672/99A Abandoned AU3567299A (en) 1998-04-17 1999-04-16 Phytosterol formulations to lower cholesterol absorption

Country Status (2)

Country Link
AU (1) AU3567299A (en)
WO (1) WO1999053925A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063776A (en) * 1998-05-26 2000-05-16 Washington University Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
DE60139550D1 (en) 2000-04-14 2009-09-24 Mars Inc COMPOSITIONS AND METHODS FOR IMPROVING VACCULAR HEALTH
PL205343B1 (en) * 2001-01-26 2010-04-30 Schering Corp The use of substituted azetidinone compounds for the treatment of sitosterolemia
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
SI1549159T1 (en) 2002-06-12 2009-04-30 Coca Cola Co Beverages containing plant sterols
US7182950B2 (en) 2002-06-12 2007-02-27 Nutralease Ltd. Nano-sized self-assembled liquid dilutable vehicles
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US7601380B2 (en) 2005-11-17 2009-10-13 Pepsico, Inc. Beverage clouding system and method
WO2009055867A1 (en) * 2007-10-31 2009-05-07 The University Of Sydney Treatment of metabolic disease
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
US5096629A (en) * 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
US5310556A (en) * 1993-06-09 1994-05-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition

Also Published As

Publication number Publication date
WO1999053925A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
HUP0302902A3 (en) Sitostanol formulation with emulsifier to reduce cholesterol absorption
AU2605499A (en) Panel structure
AU2002216470A1 (en) Cholesterol lowering supplement
AU4670799A (en) Chair structure
AU5933398A (en) Impression compositions comprising triglycerides
AU3671099A (en) Methods and compositions pertaining to pd-loops
IL139118A0 (en) Sun screen formulations
AU3567299A (en) Phytosterol formulations to lower cholesterol absorption
AU8053898A (en) Immunogenic compositions
AUPO557497A0 (en) Improvements to underpants
AU3157199A (en) Structural truss
AU4278699A (en) Improvements to pushchairs
AU3267199A (en) Improvements in or relating to headwear
AU5570899A (en) Purified human papillomavirus
AU3619399A (en) Panel structures
AUPP135598A0 (en) Improvements in or relating to comminution devices
AU3000599A (en) Moisturizing compositions
AU1450600A (en) Cholesterol 25-hydroxylase
AUPO731697A0 (en) Improvements relating to combined steel-aluminium structures
AU3454900A (en) Compositions for reducing blood cholesterol
AUPP689598A0 (en) Improvements relating to temporary structures
AU3074700A (en) Medicinal compositions with improved oral absorption
AUPQ236199A0 (en) Solar panel
AU1975399A (en) Improvements in or relating to toilets
AU3192397A (en) Cholesterol lowering pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase